MiNK Therapeutics, Inc. - Stock (INKT)

CUSIP: 603693102

Q4 2024 13F Holders as of 31 Dec 2024

Type / Class
Equity / Stock
Total 13F shares
808,382
Share change
-37,454
Total reported value
$563,868
Price per share
$0.70
Number of holders
21
Value change
-$27,574
Number of buys
4
Number of sells
11

Quarterly Holders Quick Answers

What is CUSIP 603693102?
CUSIP 603693102 identifies INKT - MiNK Therapeutics, Inc. - Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of MiNK Therapeutics, Inc. - Stock (INKT) as of Q4 2024

As of 31 Dec 2024, MiNK Therapeutics, Inc. - Stock (INKT) was held by 21 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 808,382 shares. The largest 10 holders included VANGUARD GROUP INC, Longbow Finance SA, RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, BlackRock, Inc., HighTower Advisors, LLC, STATE STREET CORP, NORTHERN TRUST CORP, Greenwich Wealth Management LLC, and WELLS FARGO & COMPANY/MN. This page lists 21 institutional shareholders reporting positions in this security for the Q4 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.